As outlined by Bayer, the company announced in August 2024 that it planned to invest more than $100 million into its St. Louis campuses while putting portions of the Creve Coeur property on the market ...

Bayer AG is preparing to announce a $10.5 billion settlement push to resolve current and future cancer lawsuits over its ...

In the seven-plus years since Bayer closed its mammoth buyout of Monsanto, the combined company has struggled to contain ...

Bayer has already paid more than $10 billion in prior verdicts and settlements and still faces roughly 67,000 active claims.” ...

Bayer has filed a false advertising lawsuit taking issue with claims made by Johnson & Johnson to pit their prostate cancer drugs against one another. | Bayer has filed a false advertising lawsuit ...

Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the ...

Patients treated with Xofigo-Xtandi experienced a 5.6-month boost to median OS over those treated with Xtandi alone.

After launching an initial “frontrunner” a group in Illinois, Bayer says its Crop Science division is ready to roll out the company’s new operating model, Dynamic Shared Ownership (as it’s known ...

Bayer's Monsanto chemical subsidiary has proposed a $7.25 billion settlement to resolve lawsuits by customers alleging that its Roundup weedkiller product caused non-Hodgkin lymphoma.

Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...

Bayer sued Johnson and Johnson, alleging false advertising for its prostate cancer drug Erleada, claiming it misleads patients.